Literature DB >> 2230143

A rapid [3H]glycerol radioassay for determination of monocyte-mediated growth inhibition of Mycobacterium avium.

D K Blanchard1, M B Michelini-Norris, J Y Djeu.   

Abstract

[3H]glycerol was used to radiolabel Mycobacterium avium (MA) bacteria after interaction with human monocytes in a rapid in vitro assay for determination of the growth inhibition of the mycobacteria by monocytes. Monocytes and MA were co-cultured in 96-well microtiter plates for 1-5 days, and [3H]glycerol was added for an additional 3 days of incubation to radiolabel residual bacteria. The results indicate that monocytes inhibited mycobacterial growth within 24 h of co-culture, an activity which increased during incubation until optimal growth inhibition was noted by 3-4 days. A comparison with conventional plate counting methodology demonstrated similar responses between the two assays except that the conventional assay required 2-3 weeks of culture before visible MA colonies could be detected and enumerated. Thus, the development of a rapid radiolabel assay to quantitate the interaction between monocytes and MA will facilitate the investigation of normal host responses to this opportunistic pathogen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230143     DOI: 10.1016/0022-1759(90)90370-b

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.

Authors:  D K Blanchard; M B Michelini-Norris; C A Pearson; S McMillen; J Y Djeu
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

2.  Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method.

Authors:  R Gomez-Flores; S Gupta; R Tamez-Guerra; R T Mehta
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

3.  In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis.

Authors:  T Hirata; H Saito; H Tomioka; K Sato; J Jidoi; K Hosoe; T Hidaka
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.